1.
Association of plasminogen activator inhibitor-1 gene promoter 4G/5G genotype polymorphism with gestational diabetes
纤溶酶原激活物抑制因子1基因启动子区4G/5G多态性与妊娠糖尿病的相关性研究
2.
Expression of Plasminogen Activator、Plasminogen Activator Inhibitor in Polycystic Ovary Syndrome
纤溶酶原激活、抑制因子在PCOS卵巢中的表达
3.
Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells
细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究
4.
The Study on Relationship between the Expression of Plasminogen Activator, Plasminogen Activator Inhibitors and Invasion and Metastasis in Ovarian Carcinoma;
纤溶酶原激活因子及其抑制因子与卵巢癌的浸润转移
5.
The expression of plasminogen activator inhibitor 1 (PAI 1) gene in human astrocytomasG
人脑星形细胞瘤纤溶酶原激活抑制因子1基因表达研究
6.
The relation of plasma plasminogen activator inhibitor activity and coronary heart disease
纤溶酶原激活抑制物活性与冠心病发病关系
7.
Relationship between plasminogen activator inhibitor 1 and neuroblastoma
纤溶酶原激活物抑制物1与神经母细胞瘤
8.
Plasminogen Activator Inhibitor-1 and Cardiovascular Diseases
纤溶酶原激活物抑制剂-1与心血管疾病
9.
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
10.
Relationship between Sepsis and a 4G/5G Polymorphism Within the Promoter Region of Plasminogen Activator Inhibitor-1 (PAI-1) Gene;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与脓毒症发生发展的相关性
11.
The Correlation between 4G/5G Polymorphism in Promoter Region of PAI-1 Gene and Coronary Artery Disease;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与冠心病的关系
12.
Relation between TNF-α in Adipose Tissue and Plasminogen Activator Inhibitor-1 in Plasma;
脂肪组织中肿瘤坏死因子-α与血浆纤溶酶原激活抑制物-1相关性的研究
13.
Expression of TNF-α protein in the omental and subcutaneous adipose tissue in obesity
肥胖者网膜脂肪肿瘤坏死因子-α的表达与血浆纤溶酶原激活抑制物-1的相关性分析
14.
Levers of von Willebrand factor,type 1 plasminogen activator inhibitor and adiponectin in coronary heart disease patients with hyperglycemia
高血糖合并冠心病患者血管性假性血友病因子、纤溶酶原激活剂抑制物及脂联素水平研究
15.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响
16.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
17.
The Role of the Plasminogen Activator Inhibitor-1 in the Pathogenesis of Hepatic Fibrosis;
纤溶酶原激活物抑制剂-1在肝纤维化发生中的作用
18.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析